Abu Dhabi to advance life sciences under new partnership

The agreement will facilitate access to Boehringer Ingelheim’s OpnME platform.

The Department of Health – Abu Dhabi has signed a memorandum of understanding with Boehringer Ingelheim to promote scientific research and innovation in the life sciences sector.

The agreement will facilitate access to Boehringer Ingelheim’s OpnME platform, allowing researchers and scientists across Abu Dhabi to use its data and resources to tackle complex biological challenges and accelerate scientific discovery.

The platform provides access to advanced compounds, collaborative opportunities, expert networks, and support for emerging talent.

It includes four flagship programmes, namely Molecule to Order (M2O), Molecule for Collaboration (M4C), opn2EXPERTS (o2e), and opnTALENTS (o25).